Okabena Investment Services Inc. Decreases Position in UnitedHealth Group Incorporated (NYSE:UNH)

Okabena Investment Services Inc. lessened its position in UnitedHealth Group Incorporated (NYSE:UNH) by 22.4% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 4,440 shares of the healthcare conglomerate’s stock after selling 1,281 shares during the quarter. UnitedHealth Group comprises 0.7% of Okabena Investment Services Inc.’s holdings, making the stock its 26th largest position. Okabena Investment Services Inc.’s holdings in UnitedHealth Group were worth $2,596,000 at the end of the most recent reporting period.

Several other large investors have also recently made changes to their positions in the company. Kathleen S. Wright Associates Inc. purchased a new stake in shares of UnitedHealth Group in the third quarter valued at approximately $27,000. Global Wealth Strategies & Associates increased its stake in shares of UnitedHealth Group by 152.4% in the 3rd quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate’s stock worth $31,000 after acquiring an additional 32 shares during the last quarter. Macroview Investment Management LLC boosted its position in shares of UnitedHealth Group by 671.4% during the 2nd quarter. Macroview Investment Management LLC now owns 54 shares of the healthcare conglomerate’s stock valued at $28,000 after acquiring an additional 47 shares during the last quarter. West Financial Advisors LLC purchased a new position in UnitedHealth Group during the third quarter worth about $32,000. Finally, Bbjs Financial Advisors LLC purchased a new stake in shares of UnitedHealth Group in the 2nd quarter valued at approximately $31,000. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

UnitedHealth Group Trading Down 1.1 %

Shares of NYSE:UNH opened at $590.87 on Friday. The company has a current ratio of 0.91, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The company’s 50 day moving average is $582.63 and its two-hundred day moving average is $552.95. The company has a market cap of $543.77 billion, a PE ratio of 38.49, a P/E/G ratio of 1.75 and a beta of 0.58. UnitedHealth Group Incorporated has a 52 week low of $436.38 and a 52 week high of $630.73.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.00 by $0.15. The business had revenue of $100.82 billion during the quarter, compared to analysts’ expectations of $99.14 billion. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The business’s quarterly revenue was up 9.2% compared to the same quarter last year. During the same period in the prior year, the firm posted $6.56 EPS. Equities analysts predict that UnitedHealth Group Incorporated will post 27.6 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, December 17th. Investors of record on Monday, December 9th will be given a $2.10 dividend. The ex-dividend date of this dividend is Monday, December 9th. This represents a $8.40 dividend on an annualized basis and a yield of 1.42%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 54.72%.

Analyst Upgrades and Downgrades

A number of research firms recently commented on UNH. KeyCorp began coverage on UnitedHealth Group in a report on Friday, October 11th. They issued an “overweight” rating and a $675.00 price objective on the stock. Truist Financial reiterated a “buy” rating and set a $625.00 price target (down from $640.00) on shares of UnitedHealth Group in a report on Wednesday, October 16th. Royal Bank of Canada lowered their target price on shares of UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating for the company in a research note on Wednesday, October 16th. Morgan Stanley reduced their price target on shares of UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating on the stock in a research note on Wednesday, October 16th. Finally, Hsbc Global Res downgraded shares of UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a report on Thursday, October 17th. Four equities research analysts have rated the stock with a hold rating, seventeen have issued a buy rating and two have given a strong buy rating to the stock. According to MarketBeat, UnitedHealth Group presently has a consensus rating of “Moderate Buy” and a consensus price target of $615.53.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.